Key result
Systemic chemotherapy yields 11-month survival in a case of metastatic chest wall angiosarcoma.
Why the study?
Primary chest wall angiosarcoma is rare and carries a poor prognosis after lung metastases.
Case Report (n=1)
No
This case report highlights the poor prognosis of chest wall angiosarcoma with lung metastases, though systemic chemotherapy may offer some survival benefit.
Single-case survival data offer no treatment guidance in metastatic chest wall angiosarcoma; leaves open optimal regimens for this rare entity.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2024) conducted a case report in Chest wall angiosarcoma with multiple lung metastases (n=1). Chemotherapy was evaluated on Overall survival. A 74-year-old man with chest wall angiosarcoma and multiple lung metastases was treated with various chemotherapies and died 11 months after diagnosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: